Metraipolis › archive › dc_d42edfcb414e

Tumor-Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy-Immunotherapy Combination Trials — Europe PMC PMID:42261253

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42261253
DOI
10.1002/ijc.70579
License (as archived)
solo-consultazione
Archived
2026-10-31T16:24:01.070Z
SHA-256 of the archived text
adbe9c193ee810d7f196f4f035d52699c1610f6d2ad5e1281c91ad77c7e7ff9a
Stable URL of this page
https://metraipolis.com/documento/dc_d42edfcb414e

How to cite

Tumor-Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy-Immunotherapy Combination Trials — Europe PMC PMID:42261253 — Europe PMC (en), https://europepmc.org/article/MED/42261253 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d42edfcb414e (Metraipolis archive dc_d42edfcb414e, sha256 adbe9c193ee810d7f196f4f035d52699c1610f6d2ad5e1281c91ad77c7e7ff9a)
BibTeX
@misc{dcd42edfcb414e,
  title = {Tumor-Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy-Immunotherapy Combination Trials — Europe PMC PMID:42261253},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42261253},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d42edfcb414e; sha256 adbe9c193ee810d7f196f4f035d52699c1610f6d2ad5e1281c91ad77c7e7ff9a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42261253. Agents can read the archived copy with the MCP tool read_document.